IMDX
Insight Molecular Diagnostics
IMDX
IMDX
26 hedge funds and large institutions have $11.4M invested in Insight Molecular Diagnostics in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
20% less capital invested
Capital invested by funds: $14.3M → $11.4M (-$2.92M)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Holders
26
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$266K | |
| 2 | +$86.8K | |
| 3 | +$19.5K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.94K |
| 5 |
Renaissance Technologies
New York
|
+$1.26K |
Top Sellers
| 1 | -$178K | |
| 2 | -$107K | |
| 3 | -$48.4K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$2.92K |
| 5 |
BlackRock
New York
|
-$265 |